- spending rises 0.8 % vs month ago.
- spending rises 4.6 % vs year ago .
Kiwi little changed at 0.8028.
Kiwi little changed at 0.8028.
Most Popular
Hims & Hers halts $49 weight-loss pill amid legal threats; Novo Nordisk's Wegovy faces competition.
EPC misses revenue targets (-11.6%) but beats EPS estimates. Guidance lowered, stock up 2.8%.
Vicuña Corp. eyes $800M+ copper investment, aiming to double 2025 spend. Huge resource potential.
Japan's Nikkei surges 4% on election clarity; gold & silver climb. US futures dip.
Eli Lilly buys Orna Therapeutics for $2.4B, boosting its drug pipeline. A big bet on future returns.
ETH dips to $2K despite $7.5K 2026 target. Bears eye $1.7K, but institutions see long-term gains.
HYPE rallies 41.5% on utility & reduced unlocks, decoupling from BTC. Ripple partnership adds fuel.
Must Read